{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-042809","form_type":"8-K","ticker":"CTSO","cik":"0001175151","company_name":"Cytosorbents Corp","filed_at":"2024-04-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.541238+00:00","generated_at":"2026-06-04T02:44:40.438361+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CytoSorbents executives take salary reduction; CEO by 35%, others by 15%","bullets":["CEO Phillip Chan reduces salary by 35% ($123,498) to $359,353 through Dec 31, 2024.","CFO Kathleen Bloch reduces salary by 15% ($46,587) to $378,413; same for other NEOs.","Board grants nonqualified stock options equal in value to each reduction at $0.95/share.","Options vest fully on Jan 31, 2025; expired 10 years from grant date.","Program aims to cut costs; salaries automatically restore to prior level after 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-042809","json":"https://secwatch.observer/filing/0001104659-24-042809.json","markdown":"https://secwatch.observer/filing/0001104659-24-042809.md","text":"https://secwatch.observer/filing/0001104659-24-042809.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1175151/000110465924042809/0001104659-24-042809-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1175151/000110465924042809/tm2410651d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T02:44:40.438361+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}